Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.

RCMI Coordinating Center (RCMI CC)

Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.

Chen X, Niu W, Fan X, Yang H, Zhao C, Fan J, Yao X, Fang Z. Oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells. Neuro Oncol. 2023 01 05; 25(1):82-96.

View in: PubMed

subject areas

Brain Neoplasms
Cell Differentiation
Cell Line, Tumor
Glioblastoma
Glioma
Humans
Lipoylation
Neoplastic Stem Cells
SOXC Transcription Factors

authors with profiles

Xuebiao Yao

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support